Trade trend analysis
Number of Transactions
Quantity
Weight
Number of Transactions
Quantity
Weight
The above chart presents the market trend analysis for shanghai kaixin pharmaceuticals co ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 11679 transactions, with a transaction quantity of 3633834.63 and a transaction weight of 4250.
-
2025
61434
12066025.16
44.2
-
2026
11679
3633834.63
4250
Bill of lading data
<
1/15
>
Products
Total 4214
-
laboratory chemicals
47770
52.59%
>
-
product id
36835
40.55%
>
-
cas no
34202
37.65%
>
-
bromo
11508
12.67%
>
-
methyl
11171
12.3%
>
+View All
Hscode rank
Total 234
-
HS 98020000
52498
57.79%
>
-
HS 29339990
26544
29.22%
>
-
HS 29335990
2472
2.72%
>
-
HS 38221990
2335
2.57%
>
-
HS 38229090
2228
2.45%
>
+View All
Port statistics
Total 3
-
shanghai
1913
1.37%
>
-
wuhan
2
0.00%
>
-
57035, shanghai
1
0.00%
>
shanghai kaixin pharmaceuticals co ltd. is china Buyer&Supplier,
and primarily engages in the import and export business of products such as laboratory chemicals,product id,cas no.
According to the 52wmb.com global trade database, as of 2026-02-28, the company has completed 140127 international trades,
The core products include HS98020000,HS29339990,HS29335990 etc,
often transported via shanghai,port wuhan, port 57035, shanghai etc,
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on shanghai kaixin pharmaceuticals co ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.